Dyno Therapeutics

Biotech · Private

AI-designed AAV capsids for gene therapy delivery

dynotherapeutics.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
40
5 granted · 35 pending
Sector median: 2

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2901FIMBRION THERAPEUTICS INC——
2902712 North Inc.——
2903SIMMBION LLC——
2904Dyno Therapeutics——
2905QUADRIGA BIOSCIENCES, INC——
2906Tubulis——
2907Lyric Therapeutics——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 5 granted of 40
  • Capsid Polypeptides And Methods Of Use Thereofapplication
  • Capsid Variants And Methods Of Using The Samegranted
  • Capsid Polypeptides And Methods Of Use Thereofapplication
  • Capsid Variants And Methods Of Using The Sameapplication
  • Capsid Polypeptides And Methods Of Use Thereofapplication
  • Capsid Polypeptides And Methods Of Use Thereofapplication
  • Capsid Variants And Methods Of Using The Samegranted
  • Capsid Variants And Methods Of Using The Sameapplication
  • Capsid Variants And Methods Of Using The Sameapplication
  • System And Methods For Predicting Features Of Biological Sequencesapplication
  • Capsid Variants And Methods Of Using The Sameapplication
  • Capsid Variants And Methods Of Using The Sameapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.